Comparative evaluation of neurovirulence of Russian and foreign live mumps vaccines

Voprosy Virusologii

Volumn 46, Issue 5, 2001, Pages 31-35

  Maximova, O A ^a   Popov, V F ^a   Bektimirov, T A ^a   Grigoryeva, L V ^a   Yunasova, T N ^a   Kaplunova, O P ^a   Sharova, O K ^a  

^a NONE

Author keywords

Mumps virus; Neurovirulence; Quantitative evaluation; Strains

Indexed keywords

MUMPS VACCINE; VIRUS ANTIBODY;

ANIMAL; ARTICLE; CERCOPITHECUS; COMPARATIVE STUDY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MACACA; NEUROLOGIC DISEASE; SPECIES DIFFERENCE; VIROLOGY; VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; FLUORESCENT ANTIBODY TECHNIQUE; MACACA MULATTA; MUMPS VACCINE; NERVOUS SYSTEM DISEASES; SPECIES SPECIFICITY; VIRULENCE;

EID: 0035459005     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Brown E. G., Furesz J., Dimock K: et al. Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients // Vaccine. - 1991. - Vol. 9. - P. 840-842.
2. Cizman M., Mozetic M., Radescek-Rakar R. et al. Aseptic meningitis after vaccination against measles and mumps // Pediatr. Infect. Dis. J. - 1989. - Vol. 8. - P. 302-308.
3. Colville A., Pugh S. Mumps meningitis and measles, mumps and rubella vaccine // Lancet. - 1992. - Vol. 340. - P. 786.
4. Coons A., Kaplan M. Localization of antigen in tissue cells // J. Exp. Med. - 1950. - Vol. 90. - P. 1-13.
5. Forsey T., Mawn J. A., Yates P. J. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing // J. Gen. Virol. - 1990. - Vol. 71. - P. 987-990.
6. Fujinada T., Motegi Y., Tamura H., Kuroume T. A prefecture - wide survey of mumps meningitis associated with measles, mumps and rubella vaccine // Pediatr. Infect. Dis. J. - 1991. - Vol. 10, N 3. - P. 204-209.
7. Galazka A. M. et al. Mumps and mumps vaccine: a global review // Bull. Wld Hlth Org. - 1999. - Vol. 77. - P. 3-14.
8. Kraiger A. Monitoring side-effects and adverse events following immunization against measles and mumps in national vaccination programme in Slovenia from 1982 to 1986. - Zagreb, 1990.
9. Levenbook I. S., Nicolaeva M. A., Chigirinsky A. E. et al. On the morphological evaluation on the neurovirulence safety of attenuated mumps virus strains in monkeys // J. Biol. Stand. - 1979. - Vol. 7. - P. 9-19.
10. Levenbook I. S., Pelleu L. J., Elisberg B. L. The monkeys safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination // J. Biol. Stand. Ibid. - 1987. - Vol. 15. - P. 305-313.
11. Maximova O., Dragunsky E., Taffs R. et al. // Biologicals. - 1996. - Vol. 24. - P. 204-209.
12. Requirements for Mumps Vaccine (Live) // WHO. Techn. Rep. Ser. - 1987. - N 760, Ann. 7. - P. 145-146.
13. Stratton K. R., Howe C. J., Johnston R. B. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. - Washington, 1994. - P. 155-159.
14. Sugiura A., Yamada A. Aseptic meningitis as a completion of mumps vaccinations // Pediatr. Infect. Dis. J. - 1991. - Vol. 10, N 3. - P. 209-213.
15. Tesovic G., Begovac J., Bace A. Aseptic meningitis after measles, mumps and rubella vaccine // Lancet. - 1993. - Vol. 341. - P. 1541.
16. US Code of Federal Regulations. Title 21, Part 630, Subpart F - Mumps Virus Vaccine Live. - Washington, 1994.